Li 1.2 Cr 0.4 Mn 0.4 O 2 (0.4LiCrO 2 ⋅0.4Li 2 MnO 3 ) is an interesting intercalation-type cathode material with high theoretical capacity of 387 mAh g -1 based on multiple-electron transfer of Cr 3+ /Cr 6+ . In this work, it has been demonstrated that the reversible Cr 3+ /Cr 6+ redox reaction can only be realized in a wide voltage range between 1.0 V and 4.8 V. This is mainly due to large polarization during the discharge. The reversible migration of the Cr ions between octahedral and tetrahedral sites leads to large extent of cation mixing between lithium and transition metal layers, which doesn't affect the lithium storage capacity and stabilize the structure. In addition, a distorted spinel phase (Li 3 M 2 O 4 ) is identified in the deeply discharged sample (1.0 V, Li 1.5 Cr 0.4 Mn 0.4 O 2 ). Above results can explain the high reversible capacity and high structural stability achieved on Li 1.2 Cr 0.4 Mn 0.4 O 2 . These new findings will provide further in depth understanding on multi-electron transferand local structure stabilization mechanisms in intercalation chemistry, which are essential for understanding and developing high capacity intercalation-type cathode for next generation high energy density Li-ion batteries.
The structure of the discharge product, Li2O2, in lithium‐oxygen batteries is revealed directly on the atomic scale. A unique stage ordering that the peroxide vacancy occupies preferentially in every other layer along the c‐axis of Li2O2 is observed. This finding provides new insight into the relationship between the structure of Li2O2 and the discharge/charge behavior of Li‐O2 batteries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.